Bayer AG and uniQure: Leading the Charge in AAV Vector Manufacturing Innovations
The Adeno-Associated Virus (AAV) vectors manufacturing market has seen significant advancements due to their growing applications in gene therapy and vaccine development. AAVs are recognized for their minimal pathogenicity, broad tissue tropism, and ability to establish long-term gene expression, making them a cornerstone in genetic disorder treatments. As the market for AAV vectors continues...
0 Σχόλια
0 Μοιράστηκε
741 Views
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)